|
Chan, Ivan H; Wu, Victoria; McCauley, Scott et al. (2015) IL-10: Expanding the Immune Oncology Horizon. Receptors Clin Investig 2:
|
|
Herynk, Matthew H; Zhang, Jing; Parikh, Nila U et al. (2007) Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J Exp Ther Oncol 6:205-17
|
|
Mumm, John B; Ekmekcioglu, Suhendan; Poindexter, Nancy J et al. (2006) Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes. J Interferon Cytokine Res 26:877-86
|
|
Hall, Christopher L; Yao, Mike; Hill, Laurie L et al. (2004) Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice. Clin Exp Metastasis 21:251-6
|
|
Hall, Christopher L; Tsan, Rachel; Mugnai, Gabriele et al. (2004) Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Prostate 59:167-76
|
|
Spurgers, Kevin B; Coombes, Kevin R; Meyn, Raymond E et al. (2004) A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells. Oncogene 23:1712-23
|
|
McCarty, M F; Bielenberg, D R; Nilsson, M B et al. (2003) Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res 13:379-87
|
|
Klos, Kristine S; Zhou, Xiaoyan; Lee, Sangkyou et al. (2003) Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone. Cancer 98:1377-85
|
|
Herynk, Matthew H; Stoeltzing, Oliver; Reinmuth, Niels et al. (2003) Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Res 63:2990-6
|
|
Herynk, Matthew H; Tsan, Rachael; Radinsky, Robert et al. (2003) Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clin Exp Metastasis 20:291-300
|
Showing the most recent 10 out of 21 publications
